Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) will report third quarter 2025 financial results and host a conference call on Wednesday, October 29, 2025 at 5:00 PM ET. The call will be available live via webcast and by telephone with advance registration; registered telephone participants receive a confirmation email with dial-in numbers, a unique passcode, and registrant ID. A replay will be accessible on the company’s Investors page.

News Market Reaction

-0.30%

1 alert

-0.30% News Effect

On the day this news was published, EBS declined 0.30%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, October 29, 2025, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2025.

Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent’s website.

About Emergent BioSolutions 
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify. 

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

FAQ

When will Emergent BioSolutions (EBS) report Q3 2025 results and hold the conference call?

EBS will report Q3 2025 results and host a conference call on October 29, 2025 at 5:00 PM ET.

How can investors listen to the Emergent BioSolutions (EBS) Q3 2025 earnings call?

Investors can listen via the live webcast on Emergent’s Investors page or by telephone after advance registration.

What do telephone participants need to join the EBS October 29, 2025 call?

Telephone participants must register in advance; registrants receive a confirmation email with dial-in numbers, a unique passcode, and registrant ID.

Where can I find the replay of Emergent BioSolutions (EBS) Q3 2025 conference call?

A replay will be available on the company’s Investors page after the call.

Is registration required to participate by phone in the EBS Q3 2025 call?

Yes, phone participation requires advance registration to obtain dial-in details and a passcode.

Will Emergent provide materials or a webcast link for the Q3 2025 results presentation?

Yes, the webcast and any related materials will be available on the company’s Investors page at the time of the call.